Sagimet ' s Shares Hit New High as Fatty Liver Disease Drug Shows Promise in Study Sagimet ' s Shares Hit New High as Fatty Liver Disease Drug Shows Promise in Study
Sagimet Biosciences said on Monday its experimental drug to treat a fatty liver disease significantly reduced the symptoms in a mid-stage study, sending the drug maker ' s...Reuters Health Information
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Gastroenterology Source Type: news
More News: Fatty Liver Disease (FLD) | Gastroenterology | Internal Medicine | Liver | Liver Disease | Study | Urology & Nephrology